Document is current
Any future updates will be listed below
-
Authors
Ferrari-Souza, João Pedro
Ferreira, Pâmela C. L.
Bellaver, Bruna
Tissot, Cécile https://orcid.org/0000-0003-2711-3833
Wang, Yi-Ting
Leffa, Douglas T.
Brum, Wagner S.
Benedet, Andréa L.
Ashton, Nicholas J.
De Bastiani, Marco Antônio https://orcid.org/0000-0003-3924-5278
Rocha, Andréia https://orcid.org/0000-0003-1567-3374
Therriault, Joseph https://orcid.org/0000-0002-7826-4781
Lussier, Firoza Z. https://orcid.org/0000-0002-6877-4825
Chamoun, Mira
Servaes, Stijn
Bezgin, Gleb
Kang, Min Su
Stevenson, Jenna
Rahmouni, Nesrine
Pallen, Vanessa
Poltronetti, Nina Margherita
Klunk, William E.
Tudorascu, Dana L.
Cohen, Ann D.
Villemagne, Victor L.
Gauthier, Serge
Blennow, Kaj https://orcid.org/0000-0002-1890-4193
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Souza, Diogo O.
Karikari, Thomas K. https://orcid.org/0000-0003-1422-4358
Zimmer, Eduardo R.
Rosa-Neto, Pedro https://orcid.org/0000-0001-9116-1376
Pascoal, Tharick A. https://orcid.org/0000-0001-9057-8014
- License Information
-
More Information
Article History
Received: 9 February 2022
Revised: 15 July 2022
Accepted: 20 July 2022
First Online: 10 August 2022
Competing interests
: SG has served as a scientific advisor to Cerveau Therapeutics. KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, AZTherapies, CogRx, Denali, Eisai, Nervgen, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. All other authors declare no competing interests.
